Healthcare Global Enterprises Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹40.86 billion
- Book Value:
- Revenue TTM:
- ₹16.17 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹7.52 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Healthcare Global Enterprises Limited had its IPO on under the ticker symbol HCG.
The company operates in the Healthcare sector and Medical Care Facilities industry. Healthcare Global Enterprises Limited has a staff strength of 5,679 employees.
Shares of Healthcare Global Enterprises Limited opened at ₹305 at the start of the last trading session i.e. 2023-05-28.
The stocks traded within a range of ₹290.1 - ₹316.5, and closed at ₹293.75.
This is a -3.37% slip from the previous day's closing price.
A total volume of 255,602 shares were traded at the close of the day’s session.
In the last one week, shares of Healthcare Global Enterprises Limited have slipped by -5.43%.
Healthcare Global Enterprises Limited's Key Ratios
Healthcare Global Enterprises Limited has a market cap of ₹40.86 billion, indicating a price to book ratio of 4.5751 and a price to sales ratio of 2.6242.
In the last 12-months Healthcare Global Enterprises Limited’s revenue was ₹16.17 billion with a gross profit of ₹7.52 billion and an EBITDA of ₹2.22 billion. The EBITDA ratio measures Healthcare Global Enterprises Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Healthcare Global Enterprises Limited’s operating margin was 7.6% while its return on assets stood at 0% with a return of equity of 0%.
In Q4, Healthcare Global Enterprises Limited’s quarterly earnings growth was a positive 41% while revenue growth was a positive 22.4%.
Healthcare Global Enterprises Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹1.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Healthcare Global Enterprises Limited’s profitability.
Healthcare Global Enterprises Limited stock is trading at a EV to sales ratio of 3.0817 and a EV to EBITDA ratio of 21.2005. Its price to sales ratio in the trailing 12-months stood at 2.6242.
Healthcare Global Enterprises Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹22.72 billion
- Total Liabilities
- ₹5.10 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Healthcare Global Enterprises Limited ended 2023 with ₹22.72 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹22.72 billion while shareholder equity stood at ₹8.81 billion.
Healthcare Global Enterprises Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹5.10 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹1.81 billion in goodwill. Its cash balance stood at ₹1.59 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹3.75 billion.
Healthcare Global Enterprises Limited’s total current assets stands at ₹5.28 billion while long-term investments were ₹0 and short-term investments were ₹372.00 million. Its net receivables were ₹2.67 billion compared to accounts payable of ₹2.29 billion and inventory worth ₹374.70 million.
In 2023, Healthcare Global Enterprises Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Healthcare Global Enterprises Limited paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Healthcare Global Enterprises Limited stock is currently trading at ₹293.75 per share. It touched a 52-week high of ₹320 and a 52-week low of ₹320. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹275.22 and 200-day moving average was ₹283.31 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7433.1% of the company’s stock are held by insiders while 779.9% are held by institutions.
Frequently Asked Questions About Healthcare Global Enterprises Limited
Similar Industry Stocks (Medical Care Facilities)
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.